CONVERSION THERAPY
Clinical trials for CONVERSION THERAPY explained in plain language.
Never miss a new study
Get alerted when new CONVERSION THERAPY trials appear
Sign up with your email to follow new studies for CONVERSION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to turn untreatable lung tumors into surgical candidates
Disease control Not yet recruitingThis phase 2 trial tests whether combining the immunotherapy drug tislelizumab with standard chemotherapy and a targeted chemo-blocking procedure (BACE) can shrink advanced, inoperable stage III non-small cell lung cancer enough to allow surgery. About 39 participants will receiv…
Matched conditions: CONVERSION THERAPY
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New tool could guide surgery timing for tough liver cancer
Disease control Not yet recruitingThis study looks at 270 people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed right away. After initial chemotherapy (GOLP regimen), participants are split into three groups: one continues medication, one goes straight to surgery, and one use…
Matched conditions: CONVERSION THERAPY
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC